BACKGROUND: Human adipose-derived stromal cells possess a great potential for tissue engineering purposes. The authors' laboratory is interested in harnessing human adipose-derived stromal cells for skeletal tissue regeneration and identifying those factors that enhance human adipose-derived stromal cell osteogenic differentiation. The authors hypothesized that insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) would stimulate human adipose-derived stromal cell osteogenesis and that IGF would stimulate adipogenesis. METHODS: Adipose-derived stromal cells were harvested from human lipoaspirate. Previously, a microarray analysis examined gene expression throughout osteogenic differentiation. In a candidate fashion, the authors added recombinant IGF-1 and PDGF-alpha individually and in combination. Osteogenesis and adipogenesis were assessed by alkaline phosphatase, alizarin red, and oil red O staining, and quantitative real-time polymerase chain reaction (RUNX2, ALP, OCN, IGF1, PPARG, LPL, AP2, and GCP1). Finally, intersection between IGF and PDGF signaling pathways was evaluated. RESULTS: IGF-1 was observed to increase osteogenic differentiation by all markers (p < 0.01). However, PDGF-alpha when added alone primarily did not affect osteogenic markers. PDGF-alpha positively regulated transcription of IGF1. Addition of PDGF-alpha in combination with or before IGF-1 enhanced osteogenesis more than either alone. IGF-1 increased whereas PDGF-alpha diminished human adipose-derived stromal cell adipogenesis. CONCLUSIONS: IGF signaling significantly increased osteogenesis in human adipose-derived stromal cells and may be used for tissue-engineering purposes. The combination of PDGF and IGF may be more beneficial than either alone in driving adipose-derived stromal cell osteogenesis. Future in vivo applications will focus on the combination of adipose-derived stromal cells, biomimetic scaffolds, and recombinant IGF.
BACKGROUND:Humanadipose-derived stromal cells possess a great potential for tissue engineering purposes. The authors' laboratory is interested in harnessing humanadipose-derived stromal cells for skeletal tissue regeneration and identifying those factors that enhance humanadipose-derived stromal cell osteogenic differentiation. The authors hypothesized that insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) would stimulate humanadipose-derived stromal cell osteogenesis and that IGF would stimulate adipogenesis. METHODS:Adipose-derived stromal cells were harvested from human lipoaspirate. Previously, a microarray analysis examined gene expression throughout osteogenic differentiation. In a candidate fashion, the authors added recombinant IGF-1 and PDGF-alpha individually and in combination. Osteogenesis and adipogenesis were assessed by alkaline phosphatase, alizarin red, and oil red O staining, and quantitative real-time polymerase chain reaction (RUNX2, ALP, OCN, IGF1, PPARG, LPL, AP2, and GCP1). Finally, intersection between IGF and PDGF signaling pathways was evaluated. RESULTS:IGF-1 was observed to increase osteogenic differentiation by all markers (p < 0.01). However, PDGF-alpha when added alone primarily did not affect osteogenic markers. PDGF-alpha positively regulated transcription of IGF1. Addition of PDGF-alpha in combination with or before IGF-1 enhanced osteogenesis more than either alone. IGF-1 increased whereas PDGF-alpha diminished humanadipose-derived stromal cell adipogenesis. CONCLUSIONS: IGF signaling significantly increased osteogenesis in humanadipose-derived stromal cells and may be used for tissue-engineering purposes. The combination of PDGF and IGF may be more beneficial than either alone in driving adipose-derived stromal cell osteogenesis. Future in vivo applications will focus on the combination of adipose-derived stromal cells, biomimetic scaffolds, and recombinant IGF.
Authors: Derrick C Wan; Yun-Ying Shi; Randall P Nacamuli; Natalina Quarto; Karen M Lyons; Michael T Longaker Journal: Proc Natl Acad Sci U S A Date: 2006-08-07 Impact factor: 11.205
Authors: Jackie Lee; Deepak Gupta; Nicholas J Panetta; Benjamin Levi; Aaron W James; Derrick Wan; George W Commons; Michael T Longaker Journal: J Craniofac Surg Date: 2010-07 Impact factor: 1.046
Authors: Malcolm Grohmann; Matthew Sabin; Jeff Holly; Julian Shield; Elizabeth Crowne; Claire Stewart Journal: J Lipid Res Date: 2004-10-16 Impact factor: 5.922
Authors: Jane B Lian; Amjad Javed; S Kaleem Zaidi; Christopher Lengner; Martin Montecino; Andre J van Wijnen; Janet L Stein; Gary S Stein Journal: Crit Rev Eukaryot Gene Expr Date: 2004 Impact factor: 1.807
Authors: W V Giannobile; R A Hernandez; R D Finkelman; S Ryan; C P Kiritsy; M D'Andrea; S E Lynch Journal: J Periodontal Res Date: 1996-07 Impact factor: 4.419
Authors: Aaron W James; Benjamin Levi; Emily R Nelson; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker Journal: Stem Cells Dev Date: 2010-10-17 Impact factor: 3.272
Authors: Benjamin Levi; Aaron W James; Emily R Nelson; Michelle Peng; Derrick C Wan; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker Journal: Plast Reconstr Surg Date: 2011-03 Impact factor: 4.730
Authors: Benjamin Levi; Aaron W James; Emily R Nelson; Shijun Hu; Ning Sun; Michelle Peng; Joseph Wu; Michael T Longaker Journal: Plast Reconstr Surg Date: 2011-03 Impact factor: 4.730
Authors: Aaron W James; Shen Pang; Asal Askarinam; Mirko Corselli; Janette N Zara; Raghav Goyal; Le Chang; Angel Pan; Jia Shen; Wei Yuan; David Stoker; Xinli Zhang; John S Adams; Kang Ting; Chia Soo Journal: Stem Cells Dev Date: 2012-02-22 Impact factor: 3.272
Authors: Jonathan R Peterson; Oluwatobi N Eboda; R Cameron Brownley; Katherine E Cilwa; Lauren E Pratt; Sara De La Rosa; Shailesh Agarwal; Steven R Buchman; Paul S Cederna; Michael D Morris; Stewart C Wang; Benjamin Levi Journal: Stem Cells Dev Date: 2015-01-15 Impact factor: 3.272
Authors: Benjamin Levi; Aaron W James; Emily R Nelson; Dean Vistnes; Benjamin Wu; Min Lee; Ankur Gupta; Michael T Longaker Journal: PLoS One Date: 2010-06-17 Impact factor: 3.240